Volume 11, Issue 4 (Nov 2023)
Res Mol Med (RMM) 2023, 11(4): 0-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Tari K, Valizadeh Ardalan P, Abroun S. Venetoclax in T-cell Acute Lymphoblastic Leukemia: The Impact of BCL-2 Inhibition on Treatment Efficacy. Res Mol Med (RMM) 2023; 11 (4)
URL: http://rmm.mazums.ac.ir/article-1-550-en.html
URL: http://rmm.mazums.ac.ir/article-1-550-en.html
1- Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2- Graduate student in Biomedical sciences, faculty of natural sciences, Bonn- Rhein Sieg university of applied sciences
3- Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran ,abroun@modares.ac.ir
2- Graduate student in Biomedical sciences, faculty of natural sciences, Bonn- Rhein Sieg university of applied sciences
3- Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran ,
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
